Predictors of Mortality in Neurosurgical Patients in a Resource-Constrained Surgical ICU: Insights from Ethiopia - Top-Institutions - MDSpire

Predictors of Mortality in Neurosurgical Patients in a Resource-Constrained Surgical ICU: Insights from Ethiopia

  • By

  • Absera Gebriel Yohannes

  • Molla Asnake Kebede

  • Amira Shamil

  • Kidus Geabriel Yohannes

  • Dejen Tekiea Gebrewahd

  • Turi Abateka Abadiga

  • Abera Kuma

  • Selemon Gebrezgabiher Asgedom

  • March 24, 2026

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Critical Care Medicine
    • Neurocritical Care

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Neurocritical Care
    • Intensive Care Medicine

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Neurocritical Care
    • Trauma Surgery

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurosurgery
    • Critical Care Medicine
    • Neurocritical Care

  • #5

    Addis Ababa University, Tikur Anbessa Specialized Hospital
    Addis Ababa University, Tikur Anbessa Specialized Hospital

    Addis Ababa, Ethiopia

    Key Differentiators

    • Neurosurgery
    • Critical Care
    • Global Health

Original Source(s)

Predictors of Mortality in Neurosurgical Patients in a Resource-Constrained Surgical ICU: Insights from Ethiopia

  • by Absera Gebriel Yohannes, Molla Asnake Kebede, Amira Shamil, Kidus Geabriel Yohannes, Dejen Tekiea Gebrewahd, Turi Abateka Abadiga, Abera Kuma, Selemon Gebrezgabiher Asgedom

  • March 24, 2026

Related Content

PT vs CBT for Chronic Low Back Pain

Sequential, multiple-assignment randomized trial compares stage I and stage II nonpharmacologic treatments over 52 weeks.

Editorial: Emerging trends in moyamoya disease: diagnostic and therapeutic innovations

Advancements in Autonomous Navigation: Utilizing Transformer Models for Catheter Tip Localization in Fluoroscopy